Michal Shauly-Aharonov
Overview
Explore the profile of Michal Shauly-Aharonov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shafrir A, Katz L, Shauly-Aharonov M, Zinger A, Safadi R, Stokar J, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610634
: Sarcopenia is underdiagnosed in patients with inflammatory bowel disease (IBD). Low alanine transaminase (ALT) is associated with sarcopenia. We evaluated the association between low ALT and the presence of...
2.
Hirshoren N, Zemer T, Shauly-Aharonov M, Weinberger J, Eliashar R
BMC Health Serv Res
. 2023 Nov;
23(1):1239.
PMID: 37951915
Background: Otorhinolaryngology / Head and Neck Surgery consists of different sub-specialties, each comprising unique characteristics and challenges. Herein, we investigate the use of a uniform national electronic questionnaire for curriculum...
3.
Shafrir A, Oster Y, Shauly-Aharonov M, Strahilevitz J
Biomedicines
. 2023 May;
11(4).
PMID: 37189635
In this study, we compared the failure rates of fosfomycin and nitrofurantoin for uncomplicated urinary tract infections. We used Meuhedet Health Services' large database to collect data on all female...
4.
Khayat A, Levine H, Berg C, Shauly-Aharonov M, Manor O, Abroms L, et al.
Tob Control
. 2022 Nov;
33(e1):e3-e10.
PMID: 36368887
Background: Tobacco regulation recently changed in Israel, including a partial advertisement ban. We assessed the impact of regulatory changes on Philip Morris International's (PMI) IQOS and cigarette advertisements. Methods: Weekly...
5.
Shafrir A, Benson A, Katz L, Hershcovici T, Bitan M, Paltiel O, et al.
Front Pharmacol
. 2022 Feb;
13:791074.
PMID: 35185561
There is conflicting evidence regarding the association between proton pump inhibitors (PPI) and the risk of acquisition and severity of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To evaluate the...
6.
Bar-Zeev Y, Shauly-Aharonov M, Neumark Y, Hirshoren N
Nicotine Tob Res
. 2022 Jan;
25(2):274-281.
PMID: 35029653
Introduction: Being on the COVID-19 frontline could negatively impact healthcare workers mental health. Aims And Methods: We examined smoking behavior changes and the association with changes in stress levels and...
7.
Shauly-Aharonov M, Shafrir A, Paltiel O, Calderon-Margalit R, Safadi R, Bicher R, et al.
PLoS One
. 2021 Jul;
16(7):e0254847.
PMID: 34293038
Importance: Patients with diabetes are known to be at increased risk for infections including severe coronavirus disease 2019 (COVID-19) but the relationship between COVID-19 severity and specific pre-infection glucose levels...
8.
Shafrir A, Shauly-Aharonov M, Katz L, Paltiel O, Pickman Y, Ackerman Z
Nutrients
. 2021 Jan;
13(1).
PMID: 33478000
Background: The success of () eradication depends on several host and treatment factors. Serum vitamin D levels may be associated with infection and eradication rates. We investigated the association between...
9.
Shauly-Aharonov M
Stat Med
. 2020 Jan;
39(8):1041-1053.
PMID: 31907979
In observational studies, it is agreed that the sensitivity of the findings to unmeasured confounders needs to be assessed. The issue is that a poor choice of test statistic can...